Paxlovid has been added to the PANORAMIC national study, the UK’s fastest-ever recruiting clinical trial of its kind, which is run by the University of Oxford in close collaboration with GP hubs. Department of Health and Social Care
Tuesday 19 April 2022
Thousands more patients to access second ground-breaking antiviral
Thousands more patients to access second ground-breaking antiviral Thousands more vulnerable people in England are now eligible to receive the UK’s second oral antiviral treatment for COVID-19.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment